Artizan Biosciences
Latest round
- Series A
Last raised
- Mar 2021
Total raised
- $14M
Investors
- 5
About Artizan Biosciences
Artizan Biosciences, Inc.Artizan Biosciences, headquartered in New Haven, US, was founded in 2016. The company specializes in the microbiome sector, providing insights into gastrointestinal diseases through precision medicine applications. Marcel de Zoete is one of the founders, and Bridget Martell and James Rosen currently serve as executives.Artizan Biosciences specializes in the development of innovative diagnostics and therapeutic solutions aimed at addressing unmet medical needs within the microbiome space. Their core product offerings focus on precision medicine applications that leverage advanced genomic technologies to analyze the gut microbiome, providing insights that can influence treatment pathways for various gastrointestinal diseases. These offerings are designed for healthcare practitioners, researchers, and pharmaceutical companies, ultimately helping to enhance patient outcomes through personalized health strategies.Artizan Biosciences generates revenue through a combination of direct-to-consumer sales and B2B partnerships with healthcare entities. Their business transactions typically involve providing diagnostic tests and related services that allow healthcare providers to offer personalized treatment recommendations based on microbiome analysis. The company’s pricing structure includes various packages for their flagship products, which are marketed to both clinical laboratories and healthcare practitioners.In March 2021, Artizan Biosciences, Inc. The company plans to develop new products addressing unmet medical needs in the microbiome sector, with strategic expansion into new markets in North America and Europe targeted for completion by the end of 2023.
Who invested in Artizan Biosciences
5 investors across 2 rounds
See all investors in Artizan Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Artizan Biosciences
Who invested in Artizan Biosciences?
Artizan Biosciences has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Artizan Biosciences raised?
Artizan Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Artizan Biosciences last raise money?
Artizan Biosciences's most recent round on record is a Series A, in Mar 2021.
What does Artizan Biosciences do?
Artizan Biosciences is a biotechnology company.
Where is Artizan Biosciences headquartered?
Artizan Biosciences is headquartered in New Haven, US.
Which VCs invest in companies like Artizan Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Artizan Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Artizan Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.